[1] Öztürk H, Özsoy M, Tuna A, et al. Investigation of hepatitis E virus seroprevalence and risk factors in hemodialysis patients[J]. Front Public Health, 2025, 13:1574361. [2] Zhang W, He Q, Wang H, et al. Hepatitis E virus infection and renal injury in non-immunocompromised host: clinical investigation and rabbit model study[J]. Front Cell Infect Microbiol, 2025, 15:1583006. [3] Molinos-Albert L M, Baquero E, Planchais C, et al. Structural basis for hepatitis E virus neutralization by potent human antibodies[J]. Sci Adv, 2025, 11(19):eadu8811. [4] 赵红娜, 魏跃光, 闫路敏, 等. 郑州地区献血者戊型肝炎病毒感染情况调查[J]. 中国输血杂志, 2025, 38(1):13-18. [5] 彭明喜, 刘奕宇, 毛湖燕, 等. 宁波地区献血者戊型肝炎病毒感染情况调查[J]. 中国输血杂志, 2025, 38(1):7-12. [6] Xie G J, Zhang H Y, Chen Q, et al. Changing etiologies and outcome of liver failure in Southwest China[J]. Virol J, 2016, 13:89. [7] Zhou X, Luo J, Liang X, et al. Plasma thrombomodulin as a candidate biomarker for the diagnosis and prognosis of HBV-related acute-on-chronic liver failure[J]. Infect Drug Resist, 2024, 17:1185-1198. [8] Kupke P, Kupke M, Borgmann S, et al. Hepatitis E virus infection in immunosuppressed patients and its clinical manifestations[J]. Dig Liver Dis, 2025, 57(2):378-384. [9] Sacristán C, Ewbank AC, Duarte-Benvenuto A, et al. Survey of selected viral agents (herpesvirus, adenovirus and hepatitis E virus) in liver and lung samples of cetaceans, Brazil[J]. Sci Rep, 2024, 14(1):2689. [10] 高朋彬, 赵晓彦, 秦浩, 等. 戊型肝炎肝衰竭死亡原因分析[J]. 实用肝脏病杂志, 2019, 22(2):220-223. [11] 陈晓云, 刘晓慧, 宋静静, 等. 急性戊型肝炎肝衰竭不良预后的影响因素分析[J]. 北京医学, 2022, 44(10):935-938. [12] 中国医师协会感染科医师分会. 戊型病毒性肝炎诊疗规范[J]. 中华临床感染病杂志, 2009, 2:260-263. [13] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 中华临床感染病杂志, 2018, 11:401-410. [14] Schmidt L E, Larsen F S. Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure[J]. Crit Care Med, 2006, 34(2):337-343. [15] Zaccherini G, Aguilar F, Caraceni P, et al. Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF[J]. J Hepatol, 2021, 74(5):1117-1131. |